| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |